Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||INHIBITION OF INSULIN RELEASE BY JATROPHONE|
|Abstract:||In many countries, including Brazil, extracts of Jatrophona elliptica species are currently used for the treatment of several diseases. Recently it was shown that a purified compound from these plants inhibits contraction of smooth and cardiac muscle in the mu-M range, probably involving alterations in membrane Ca2+ permeability and/or internal Ca2+ distribution. In collagenase-isolated rat islets and in the absence of glucose, basal insulin secretion measured by radioimmunoassay averaged 122 13-mu-U/islet per 90 min (N = 25). At 16.7 mM glucose, the insulin output reached 445 +/- 32-mu-U/islet per 90 min (N = 27). Jatrophone (1-100-mu-M/l) caused a dose-related inhibition of glucose-induced insulin release, over basal secretion, with an ID50 close to 8-mu-M/l. Complete inhibition of insulin release was obtained with 100-mu-M/l Jatrophone. However, at 100-mu-M/l (but not at 10-mu-M/l) concentration, Jatrophone also provoked a reduction in glucose metabolism by the islets which could explain, at least in part, the reduction in insulin secretion. After 120-min incubation, the glucose metabolism, measured by the (CO2)-O-14 production, was reduced from 26.58 +/- 3.63 (N = 42) to 7.48 +/- 1.36 (N = 16) pmol/l per islet. In conclusion, at lower concentrations (10-mu-M/l) Jatrophone could be a valuable tool for the study of the mechanism of insulin release induced either by glucose or other secretagogues.|
|Editor:||Assoc Bras Divulg Cientifica|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.